Multiple Sclerosis Clinical Trials

Showing 5741-5760 of 5,960 trials

Clinical Characteristics of Patients Under the Age 21 Years Who Underwent Gynecological Surgery

NCT00928369

Young patients with adnexal lesions may have variable presenting symptoms. In this study, we reviewed the clinical characteristics of young Korean patients who took the operation in university hospital with adnexal lesions over the past 14 years.

Demographic FindingsPresenting Symptoms on First Hospital VisitPreoperative Radiologic Findings+2 more

Samsung Medical Center494 participantsStarted May 2009

COMPLETEDPhase 2

NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)

NCT00916097

Primary Objective: To estimate the overall response rate after neo-adjuvant chemotherapy of Docetaxel 75 mg/m2 in combination with Cisplatin 75 mg/m2 given for 3 cycles, and followed by conventional radiotherapy in UCNT. Secondary Objectives: To evaluate: * The radiological response after chemotherapy and radiotherapy * The pathological response after chemotherapy by cavum biopsy To estimate: * The duration of overall response * The time to progression (T.T.P) To analyze: * The overall survival * The safety profile

Head and Neck Neoplasms

Sanofi66 participantsStarted Jul 2002

Algiers, Algeria • Casablanca, Morocco • Mégrine, Tunisia

COMPLETEDNA

EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis

NCT00137176

The primary purpose is to determine the changes in gene expression induced by IFNb-1a (Rebif) and atorvastatin (Lipitor) combination therapy in patients with an isolated clinical syndrome suggestive of multiple sclerosis (MS), to identify markers of therapeutic response, and to predict patients' clinical response based on their in vitro response to this combination therapy measured by the gene expression levels in activated peripheral blood mononuclear cells (PBMCs).

Multiple Sclerosis

University of North Carolina, Chapel Hill30 participantsStarted Oct 2004

Chapel Hill, North Carolina, United States

Clinical Characteristics of Patients Under the Age 21 Years Who Underwent Gynecological Surgery

NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)

EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis

Related Searches

Open-Label Natalizumab Safety Extension Study

Immunogenicity and Safety Study of Serum-Free Avonex

Open-Label Safety Extension Study of Avonex

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women

Identification of Hepatic Lesions

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia

Motor Imagery Practice in Neurological Rehabilitation